Tokyo, Sept. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062786) titled 'A Randomized Phase III Study Comparing Pathology Artificial Intelligence (AI)- and Circulating Tumor DNA (ctDNA)-Guided Adjuvant Chemotherapy with Standard Adjuvant Therapy for Patients with Curatively Resected High-Risk Stage II and Stage III Colon Cancer' on Sept. 2.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Active
Primary Sponsor:
Institute - National Cancer Center Hospital East
Condition:
Condition - Patients with Curatively Resected High-Risk Stage II and Stage III Colon Cancer
Classification by malignancy - Malign...